This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Ucbbiopharma Srl. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Foteini Strimenopoulou: Innovator in Therapeutic Antibody Treatments
Introduction
Foteini Strimenopoulou is a prominent inventor based in Slough, GB. She has made significant contributions to the field of therapeutic treatments, particularly through her innovative work with antibody molecules.
Latest Patents
Strimenopoulou holds a patent for "Methods of treatment using anti-IL-17A/F antibodies." This invention focuses on the therapeutic uses of antibody molecules that target both IL-17A and IL-17F. The applications of her work are particularly relevant in treating dermatological and rheumatological diseases, including psoriasis, psoriatic arthritis, and axial spondyloarthritis. She has been awarded 1 patent for her groundbreaking research.
Career Highlights
Foteini Strimenopoulou is associated with Ucb Biopharma Srl, where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the field of antibody therapies.
Collaborations
Strimenopoulou collaborates with notable colleagues, including Sophie Glatt and Lucian Ionescu, to further enhance the impact of her research.
Conclusion
Foteini Strimenopoulou's innovative contributions to therapeutic antibody treatments highlight her role as a leading inventor in the medical field. Her work promises to improve the lives of many suffering from chronic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile